ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ERAS

Rosen Law Firm is notifying investors who purchased Erasca, Inc. (ERAS) stock between January 14, 2025 and April 26, 2026 about a securities class action lawsuit. The lawsuit alleges that Erasca and its executives made false and misleading statements about its lead oncology drug candidate ERAS-0015, including improper comparisons to a competing drug and undisclosed patent disputes. The deadline to serve as lead plaintiff is August 10, 2026.